ParagonRx® | Minimize Risk and Optimize Use

The special, two-day conference will address the pressing issues that drug safety experts are facing today. Safety issues can arise throughout the life-history of a drug, from preclinical screening through to the clinic and after launch. Thus, the conference is co-located with our annual “Post-Approval Drug Safety” meeting and will offer shared sessions and networking in order to facilitate inter-disciplinary sharing of ideas in an informal setting.

For more information:  www.healthtech.com/ptx